| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.584 | 0.005 | 0.633 | Sigma receptor agonist | 0.633 0.004 DBMET01778 | DBMET01778 | |
| 0.562 | 0.01 | 0.562 | Hypoglycemic | 0.458 0.02 DBMET01778 | ||
| 0.469 | 0.043 | 0.469 | 5 Hydroxytryptamine release inhibitor | 0.341 0.123 DBMET00287 0.448 0.052 DBMET01778 | ||
| 0.406 | 0.021 | 0.416 | Psychostimulant | 0.416 0.02 DBMET01778 | DBMET01778 | |
| 0.383 | 0.008 | 0.579 | Nav1.2 sodium channel blocker | 0.106 0.102 DBMET00287 0.579 0.004 DBMET01778 | DBMET01778 | |
| 0.364 | 0.015 | 0.411 | Diuretic | 0.122 0.103 DBMET00287 0.411 0.012 DBMET01778 | DBMET01778 | |
| 0.337 | 0.003 | 0.337 | Folate antagonist | 0.32 0.003 DBMET00287 0.203 0.009 DBMET01778 | ||
| 0.336 | 0.005 | 0.336 | Neuropeptide Y antagonist | 0.232 0.011 DBMET01778 | ||
| 0.328 | 0.024 | 0.599 | Anticoagulant | 0.599 0.006 DBMET01778 | DBMET01778 | |
| 0.303 | 0.005 | 0.366 | CXC chemokine 4 receptor antagonist | 0.366 0.004 DBMET01778 | DBMET01778 | |
| 0.343 | 0.049 | 0.486 | Interleukin 2 agonist | 0.486 0.01 DBMET01778 | DBMET01778 | |
| 0.299 | 0.008 | 0.365 | Nav1.1 sodium channel blocker | 0.365 0.005 DBMET01778 | DBMET01778 | |
| 0.291 | 0.004 | 0.493 | 5 Hydroxytryptamine 3A agonist | 0.1 0.076 DBMET00287 0.493 0.001 DBMET01778 | DBMET01778 | |
| 0.292 | 0.005 | 0.292 | Neuropeptide Y1 antagonist | 0.247 0.009 DBMET01778 | ||
| 0.272 | 0.005 | 0.272 | Interleukin 2 antagonist | 0.167 0.013 DBMET01778 | ||
| 0.277 | 0.014 | 0.306 | Sodium channel blocker | 0.306 0.01 DBMET01778 | DBMET01778 | |
| 0.3 | 0.058 | 0.361 | Insulysin inhibitor | 0.361 0.03 DBMET01778 | DBMET01778 | |
| 0.274 | 0.035 | 0.298 | Neuropeptide Y2 antagonist | 0.298 0.019 DBMET01778 | DBMET01778 | |
| 0.334 | 0.095 | 0.387 | Antiobesity | 0.387 0.071 DBMET01778 | DBMET01778 | |
| 0.344 | 0.105 | 0.375 | Antibacterial | 0.375 0.089 DBMET00287 0.368 0.092 DBMET01778 | DBMET00287 | |
| 0.281 | 0.052 | 0.328 | Interleukin antagonist | 0.328 0.042 DBMET01778 | DBMET01778 | |
| 0.276 | 0.048 | 0.404 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.404 0.014 DBMET01778 | DBMET01778 | |
| 0.346 | 0.125 | 0.346 | Cyclophilin D inhibitor | 0.346 0.125 DBMET01778 | ||
| 0.227 | 0.006 | 0.327 | Nitric-oxide synthase inhibitor | 0.327 0.004 DBMET01778 | DBMET01778 | |
| 0.28 | 0.06 | 0.544 | Platelet antagonist | 0.544 0.01 DBMET01778 | DBMET01778 | |
| 0.23 | 0.019 | 0.23 | ATPase inhibitor | 0.151 0.1 DBMET00287 0.177 0.061 DBMET01778 | ||
| 0.272 | 0.062 | 0.272 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.142 DBMET00287 0.258 0.073 DBMET01778 | ||
| 0.218 | 0.008 | 0.402 | Cell adhesion molecule inhibitor | 0.402 0.004 DBMET01778 | DBMET01778 | |
| 0.213 | 0.004 | 0.368 | NMDA 2A receptor antagonist | 0.368 0.003 DBMET01778 | DBMET01778 | |
| 0.216 | 0.009 | 0.357 | AMP-activated protein kinase stimulant | 0.357 0.004 DBMET01778 | DBMET01778 | |
| 0.235 | 0.03 | 0.235 | Thiol protease inhibitor | 0.186 0.045 DBMET01778 | ||
| 0.268 | 0.071 | 0.305 | Cardiotonic | 0.305 0.054 DBMET01778 | DBMET01778 | |
| 0.204 | 0.014 | 0.437 | NMDA receptor antagonist | 0.437 0.004 DBMET01778 | DBMET01778 | |
| 0.194 | 0.004 | 0.22 | Maillard reaction inhibitor | 0.22 0.004 DBMET01778 | DBMET01778 | |
| 0.201 | 0.024 | 0.339 | Cell adhesion inhibitor | 0.339 0.008 DBMET01778 | DBMET01778 | |
| 0.242 | 0.074 | 0.242 | Vasodilator | |||
| 0.169 | 0.004 | 0.169 | Potassium channel (ATP-sensitive) blocker | 0.149 0.005 DBMET01778 | ||
| 0.22 | 0.055 | 0.263 | Insulin sensitizer | 0.263 0.027 DBMET01778 | DBMET01778 | |
| 0.165 | 0.006 | 0.241 | Neuraminidase (influenza) inhibitor | 0.241 0.004 DBMET01778 | DBMET01778 | |
| 0.243 | 0.084 | 0.346 | Interleukin agonist | 0.346 0.03 DBMET01778 | DBMET01778 | |
| 0.24 | 0.086 | 0.24 | DNA damaging | 0.238 0.087 DBMET01778 | ||
| 0.155 | 0.003 | 0.189 | Epithelial sodium channel blocker | 0.189 0.002 DBMET01778 | DBMET01778 | |
| 0.24 | 0.091 | 0.242 | Gastrin inhibitor | 0.242 0.089 DBMET01778 | DBMET01778 | |
| 0.326 | 0.179 | 0.4 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.296 0.218 DBMET00287 0.4 0.101 DBMET01778 | DBMET01778 | |
| 0.188 | 0.042 | 0.236 | Neurotensin receptor agonist | 0.236 0.024 DBMET01778 | DBMET01778 | |
| 0.159 | 0.015 | 0.38 | NMDA 2 receptor antagonist | 0.38 0.004 DBMET01778 | DBMET01778 | |
| 0.151 | 0.01 | 0.191 | CXC chemokine receptor antagonist | 0.191 0.006 DBMET01778 | DBMET01778 | |
| 0.15 | 0.01 | 0.191 | Glutamate release inhibitor | 0.138 0.013 DBMET00287 0.191 0.005 DBMET01778 | DBMET01778 | |
| 0.162 | 0.026 | 0.162 | Falcipain inhibitor | 0.08 0.073 DBMET01778 | ||
| 0.207 | 0.071 | 0.393 | Anesthetic general | 0.146 0.119 DBMET00287 0.393 0.017 DBMET01778 | DBMET01778 | |
| 0.16 | 0.025 | 0.16 | Falcipain 2 inhibitor | 0.077 0.074 DBMET01778 | ||
| 0.149 | 0.019 | 0.194 | Factor V inhibitor | 0.194 0.006 DBMET01778 | DBMET01778 | |
| 0.136 | 0.008 | 0.221 | Neuraminidase inhibitor | 0.221 0.004 DBMET01778 | DBMET01778 | |
| 0.223 | 0.095 | 0.465 | Superoxide dismutase inhibitor | 0.465 0.017 DBMET01778 | DBMET01778 | |
| 0.135 | 0.009 | 0.277 | Urokinase inhibitor | 0.277 0.004 DBMET01778 | DBMET01778 | |
| 0.157 | 0.041 | 0.208 | Cathepsin H inhibitor | 0.208 0.02 DBMET01778 | DBMET01778 | |
| 0.145 | 0.03 | 0.215 | Nav1.5 sodium channel blocker | 0.215 0.01 DBMET01778 | DBMET01778 | |
| 0.117 | 0.009 | 0.328 | 5 Hydroxytryptamine 3 agonist | 0.328 0.003 DBMET01778 | DBMET01778 | |
| 0.108 | 0.004 | 0.108 | Potassium channel (Inward rectifier) activator | 0.056 0.025 DBMET01778 | ||
| 0.117 | 0.014 | 0.117 | Sigma receptor antagonist | 0.082 0.02 DBMET01778 | ||
| 0.106 | 0.004 | 0.201 | Diamine oxidase inhibitor | 0.201 0.003 DBMET01778 | DBMET01778 | |
| 0.105 | 0.004 | 0.105 | Potassium channel (ATP-sensitive) activator | 0.053 0.024 DBMET01778 | ||
| 0.252 | 0.153 | 0.449 | GABA C receptor rho-3 antagonist | 0.449 0.042 DBMET00287 0.369 0.076 DBMET01778 | DBMET00287 | |
| 0.111 | 0.015 | 0.111 | Cathepsin D inhibitor | |||
| 0.108 | 0.013 | 0.188 | Plasminogen activator inhibitor | 0.188 0.005 DBMET01778 | DBMET01778 | |
| 0.105 | 0.011 | 0.128 | Melanocortin antagonist | 0.128 0.009 DBMET01778 | DBMET01778 | |
| 0.234 | 0.14 | 0.304 | Antithrombotic | 0.304 0.085 DBMET01778 | DBMET01778 | |
| 0.106 | 0.013 | 0.129 | Alpha 2 adrenoreceptor agonist | 0.129 0.009 DBMET01778 | DBMET01778 | |
| 0.099 | 0.009 | 0.11 | Melanocortin 4 antagonist | 0.11 0.009 DBMET01778 | DBMET01778 | |
| 0.097 | 0.007 | 0.097 | Potassium channel (Inward rectifier) blocker | 0.072 0.016 DBMET01778 | ||
| 0.098 | 0.008 | 0.23 | Smo receptor antagonist | 0.23 0.005 DBMET01778 | DBMET01778 | |
| 0.13 | 0.044 | 0.207 | Nav1.4 sodium channel blocker | 0.151 0.033 DBMET00287 0.207 0.018 DBMET01778 | DBMET01778 | |
| 0.107 | 0.022 | 0.26 | Thrombin inhibitor | 0.26 0.005 DBMET01778 | DBMET01778 | |
| 0.191 | 0.106 | 0.22 | Nitric-oxide synthase stimulant | 0.211 0.071 DBMET00287 0.22 0.06 DBMET01778 | DBMET01778 | |
| 0.109 | 0.025 | 0.179 | Neuropeptide agonist | 0.179 0.007 DBMET01778 | DBMET01778 | |
| 0.137 | 0.054 | 0.137 | Alkylator | 0.109 0.079 DBMET01778 | ||
| 0.109 | 0.027 | 0.125 | Histamine H2 receptor antagonist | 0.125 0.018 DBMET01778 | DBMET01778 | |
| 0.191 | 0.11 | 0.201 | Aldehyde oxidase inhibitor | 0.201 0.104 DBMET01778 | DBMET01778 | |
| 0.084 | 0.005 | 0.084 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET01778 | ||
| 0.083 | 0.005 | 0.158 | Endothelial nitric-oxide synthase inhibitor | 0.158 0.003 DBMET01778 | DBMET01778 | |
| 0.082 | 0.005 | 0.127 | Neuraminidase (Influenza A) inhibitor | 0.127 0.004 DBMET01778 | DBMET01778 | |
| 0.093 | 0.016 | 0.181 | Protease activated receptor 1 antagonist | 0.181 0.004 DBMET01778 | DBMET01778 | |
| 0.153 | 0.076 | 0.185 | Hexokinase inhibitor | 0.185 0.045 DBMET01778 | DBMET01778 | |
| 0.094 | 0.019 | 0.227 | Trypsin inhibitor | 0.227 0.005 DBMET01778 | DBMET01778 | |
| 0.077 | 0.005 | 0.465 | Dihydrofolate reductase inhibitor | 0.465 0.001 DBMET00287 0.068 0.007 DBMET01778 | DBMET00287 | |
| 0.164 | 0.092 | 0.358 | Platelet adhesion inhibitor | 0.358 0.018 DBMET01778 | DBMET01778 | |
| 0.15 | 0.082 | 0.274 | Thrombolytic | 0.274 0.028 DBMET01778 | DBMET01778 | |
| 0.089 | 0.022 | 0.109 | Argininosuccinate synthase inhibitor | 0.109 0.017 DBMET01778 | DBMET01778 | |
| 0.078 | 0.012 | 0.205 | NMDA receptor subunit 3A antagonist | 0.205 0.004 DBMET01778 | DBMET01778 | |
| 0.225 | 0.159 | 0.225 | Vasodilator, coronary | |||
| 0.193 | 0.128 | 0.193 | 5 Hydroxytryptamine release stimulant | 0.184 0.136 DBMET00287 0.17 0.152 DBMET01778 | ||
| 0.132 | 0.067 | 0.132 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 DBMET01778 | ||
| 0.122 | 0.059 | 0.167 | Interleukin 8 antagonist | 0.167 0.025 DBMET01778 | DBMET01778 | |
| 0.098 | 0.035 | 0.098 | Somatostatin 1 agonist | |||
| 0.132 | 0.071 | 0.183 | Sodium channel (voltage-gated) blocker | 0.183 0.036 DBMET01778 | DBMET01778 | |
| 0.104 | 0.044 | 0.104 | Potassium channel activator | |||
| 0.098 | 0.039 | 0.185 | Inducible nitric-oxide synthase inhibitor | 0.185 0.01 DBMET01778 | DBMET01778 | |
| 0.217 | 0.158 | 0.345 | Ca(v)3.3 blocker | 0.345 0.016 DBMET01778 | DBMET01778 | |
| 0.073 | 0.015 | 0.213 | Factor X inhibitor | 0.213 0.005 DBMET01778 | DBMET01778 | |
| 0.101 | 0.045 | 0.123 | Histamine N-methyltransferase inhibitor | 0.098 0.048 DBMET00287 0.123 0.028 DBMET01778 | DBMET01778 | |
| 0.067 | 0.01 | 0.067 | Bradykinin antagonist | 0.034 0.03 DBMET01778 | ||
| 0.139 | 0.083 | 0.254 | Hemostatic | 0.254 0.021 DBMET01778 | DBMET01778 | |
| 0.181 | 0.127 | 0.235 | Peptidyltransferase inhibitor | 0.235 0.062 DBMET01778 | DBMET01778 | |
| 0.069 | 0.015 | 0.176 | Factor VIIa inhibitor | 0.176 0.006 DBMET01778 | DBMET01778 | |
| 0.111 | 0.058 | 0.166 | Aminopeptidase B inhibitor | 0.166 0.031 DBMET01778 | DBMET01778 | |
| 0.057 | 0.005 | 0.057 | Bradykinin B2 receptor antagonist | 0.051 0.006 DBMET01778 | ||
| 0.074 | 0.023 | 0.098 | Corticotropin releasing factor 2 receptor antagonist | 0.098 0.007 DBMET01778 | DBMET01778 | |
| 0.085 | 0.035 | 0.085 | Alpha adrenoreceptor agonist | 0.076 0.041 DBMET01778 | ||
| 0.071 | 0.021 | 0.095 | Sphingosine kinase 2 inhibitor | 0.095 0.009 DBMET01778 | DBMET01778 | |
| 0.067 | 0.019 | 0.137 | Complement C3a chemotactic receptor antagonist | 0.137 0.004 DBMET01778 | DBMET01778 | |
| 0.057 | 0.009 | 0.057 | Sigma 1 receptor antagonist | 0.023 0.021 DBMET01778 | ||
| 0.076 | 0.028 | 0.226 | NMDA 2C receptor antagonist | 0.226 0.005 DBMET01778 | DBMET01778 | |
| 0.061 | 0.014 | 0.082 | Histamine H2 receptor agonist | 0.082 0.007 DBMET01778 | DBMET01778 | |
| 0.067 | 0.021 | 0.067 | Histamine agonist | 0.066 0.022 DBMET01778 | ||
| 0.092 | 0.046 | 0.153 | Hematopoietic | 0.153 0.015 DBMET01778 | DBMET01778 | |
| 0.07 | 0.024 | 0.182 | Kallikrein 1 inhibitor | 0.182 0.005 DBMET01778 | DBMET01778 | |
| 0.09 | 0.049 | 0.146 | Factor XII inhibitor | 0.146 0.014 DBMET01778 | DBMET01778 | |
| 0.054 | 0.013 | 0.064 | Histamine H1 receptor agonist | 0.064 0.006 DBMET01778 | DBMET01778 | |
| 0.068 | 0.027 | 0.107 | Botulinum neurotoxin type A inhibitor | 0.107 0.008 DBMET01778 | DBMET01778 | |
| 0.105 | 0.065 | 0.155 | Falcipain 3 inhibitor | 0.155 0.034 DBMET01778 | DBMET01778 | |
| 0.171 | 0.132 | 0.181 | 5 Hydroxytryptamine 3E antagonist | 0.178 0.112 DBMET00287 0.181 0.102 DBMET01778 | DBMET01778 | |
| 0.086 | 0.05 | 0.086 | Adrenaline agonist | |||
| 0.147 | 0.112 | 0.24 | Phospholipase C inhibitor | 0.24 0.027 DBMET01778 | DBMET01778 | |
| 0.036 | 0.003 | 0.04 | Prokineticin receptor 1 antagonist | 0.04 0.002 DBMET01778 | DBMET01778 | |
| 0.058 | 0.025 | 0.062 | Bombesin 2 receptor antagonist | 0.062 0.023 DBMET01778 | DBMET01778 | |
| 0.054 | 0.022 | 0.187 | NMDA receptor subunit 3B antagonist | 0.187 0.005 DBMET01778 | DBMET01778 | |
| 0.034 | 0.003 | 0.034 | Potassium channel (Inward rectifier) 11 blocker | 0.022 0.006 DBMET01778 | ||
| 0.075 | 0.045 | 0.075 | Calcium channel L-type blocker | |||
| 0.076 | 0.046 | 0.208 | Histidine decarboxylase inhibitor | 0.208 0.012 DBMET01778 | DBMET01778 | |
| 0.043 | 0.015 | 0.116 | Trypsin I inhibitor | 0.116 0.005 DBMET01778 | DBMET01778 | |
| 0.063 | 0.034 | 0.072 | Sphingosine kinase inhibitor | 0.072 0.023 DBMET01778 | DBMET01778 | |
| 0.091 | 0.063 | 0.104 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 DBMET01778 | DBMET01778 | |
| 0.062 | 0.035 | 0.081 | Gonadotropin-releasing hormone receptor agonist | 0.081 0.017 DBMET01778 | DBMET01778 | |
| 0.056 | 0.029 | 0.181 | Plasmin inhibitor | 0.181 0.007 DBMET01778 | DBMET01778 | |
| 0.065 | 0.041 | 0.084 | Kallikrein 7 inhibitor | 0.084 0.011 DBMET01778 | DBMET01778 | |
| 0.036 | 0.015 | 0.068 | Trypsin II inhibitor | 0.068 0.006 DBMET01778 | DBMET01778 | |
| 0.074 | 0.054 | 0.074 | Vanilloid 4 agonist | |||
| 0.193 | 0.173 | 0.193 | Immunomodulator | |||
| 0.027 | 0.008 | 0.029 | Histamine H4 receptor agonist | 0.029 0.007 DBMET01778 | DBMET01778 | |
| 0.04 | 0.022 | 0.244 | Tryptase inhibitor | 0.244 0.004 DBMET01778 | DBMET01778 | |
| 0.032 | 0.015 | 0.071 | Thrombin receptor antagonist | 0.071 0.006 DBMET01778 | DBMET01778 | |
| 0.142 | 0.128 | 0.187 | Succinate dehydrogenase inhibitor | 0.145 0.123 DBMET00287 0.187 0.061 DBMET01778 | DBMET01778 | |
| 0.024 | 0.009 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET01778 | DBMET01778 | |
| 0.091 | 0.077 | 0.101 | Anabolic | 0.101 0.061 DBMET01778 | DBMET01778 | |
| 0.071 | 0.057 | 0.113 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.06 DBMET00287 0.113 0.008 DBMET01778 | DBMET01778 | |
| 0.021 | 0.008 | 0.18 | Sodium/hydrogen exchanger inhibitor | 0.18 0.002 DBMET01778 | DBMET01778 | |
| 0.039 | 0.026 | 0.061 | Melanocortin 1 antagonist | 0.061 0.017 DBMET01778 | DBMET01778 | |
| 0.027 | 0.015 | 0.036 | Complement factor 1r inhibitor | 0.036 0.006 DBMET01778 | DBMET01778 | |
| 0.046 | 0.034 | 0.132 | Kallikrein inhibitor | 0.132 0.007 DBMET01778 | DBMET01778 | |
| 0.041 | 0.03 | 0.047 | Sphingosine kinase 1 inhibitor | 0.047 0.02 DBMET01778 | DBMET01778 | |
| 0.092 | 0.081 | 0.188 | Ferrochelatase inhibitor | 0.115 0.057 DBMET00287 0.188 0.025 DBMET01778 | DBMET01778 | |
| 0.059 | 0.048 | 0.13 | Protease activated receptor antagonist | 0.13 0.007 DBMET01778 | DBMET01778 | |
| 0.096 | 0.087 | 0.096 | Anesthetic local | |||
| 0.188 | 0.181 | 0.188 | Transcription factor NF kappa B inhibitor | |||
| 0.052 | 0.046 | 0.267 | 5 Hydroxytryptamine 3 antagonist | 0.267 0.004 DBMET01778 | DBMET01778 | |
| 0.012 | 0.007 | 0.034 | Melatonin 5 antagonist | 0.034 0.003 DBMET01778 | DBMET01778 | |
| 0.06 | 0.056 | 0.077 | Calcium channel P-type blocker | 0.077 0.018 DBMET01778 | DBMET01778 | |
| 0.129 | 0.126 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.024 DBMET01778 | DBMET01778 | |
| 0.043 | 0.042 | 0.043 | Bombesin antagonist | |||
| 0.111 | 0.11 | 0.232 | Peroxidase inhibitor | 0.149 0.079 DBMET00287 0.232 0.051 DBMET01778 | DBMET01778 | |
| 0.031 | 0.03 | 0.064 | Factor XI inhibitor | 0.064 0.006 DBMET01778 | DBMET01778 | |
| 0.018 | 0.018 | 0.104 | Vitronectin receptor antagonist | 0.104 0.005 DBMET01778 | DBMET01778 | |
| 0.017 | 0.017 | 0.154 | Integrin beta3 antagonist | 0.154 0.004 DBMET01778 | DBMET01778 | |
| 0.028 | 0.031 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.027 DBMET01778 | DBMET01778 | |
| 0.034 | 0.036 | 0.056 | Erythropoietin receptor agonist | 0.056 0.019 DBMET01778 | DBMET01778 | |
| 0.015 | 0.018 | 0.024 | Complement factor 1 inhibitor | 0.024 0.005 DBMET01778 | DBMET01778 | |
| 0.017 | 0.02 | 0.059 | Integrin beta5 antagonist | 0.059 0.005 DBMET01778 | DBMET01778 | |
| 0.022 | 0.026 | 0.06 | Lysine carboxypeptidase inhibitor | 0.06 0.006 DBMET01778 | DBMET01778 | |
| 0.021 | 0.025 | 0.058 | Melanocortin 5 antagonist | 0.058 0.01 DBMET01778 | DBMET01778 | |
| 0.076 | 0.081 | 0.104 | D-Ala-D-Ala ligase inhibitor | 0.087 0.05 DBMET00287 0.104 0.025 DBMET01778 | DBMET01778 | |
| 0.05 | 0.056 | 0.087 | 5 Hydroxytryptamine 5 antagonist | 0.087 0.018 DBMET01778 | DBMET01778 | |
| 0.034 | 0.039 | 0.066 | Factor XIa inhibitor | 0.066 0.01 DBMET01778 | DBMET01778 | |
| 0.023 | 0.029 | 0.081 | Factor VII inhibitor | 0.081 0.008 DBMET01778 | DBMET01778 | |
| 0.11 | 0.116 | 0.171 | Cell wall synthesis inhibitor | 0.171 0.046 DBMET01778 | DBMET01778 | |
| 0.149 | 0.156 | 0.243 | Immunostimulant | 0.243 0.099 DBMET01778 | DBMET01778 | |
| 0.037 | 0.044 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.049 0.015 DBMET01778 | DBMET01778 | |
| 0.03 | 0.037 | 0.122 | Integrin antagonist | 0.122 0.013 DBMET01778 | DBMET01778 | |
| 0.022 | 0.03 | 0.037 | Complement factor 1s inhibitor | 0.037 0.004 DBMET01778 | DBMET01778 | |
| 0.013 | 0.021 | 0.12 | Melatonin 3 antagonist | 0.12 0.004 DBMET01778 | DBMET01778 | |
| 0.059 | 0.068 | 0.157 | Telomerase inhibitor | 0.157 0.019 DBMET01778 | DBMET01778 | |
| 0.061 | 0.07 | 0.095 | Secretase beta inhibitor | 0.065 0.059 DBMET00287 0.095 0.021 DBMET01778 | DBMET01778 | |
| 0.04 | 0.051 | 0.072 | Ornithine carbamoyltransferase inhibitor | 0.072 0.025 DBMET01778 | DBMET01778 | |
| 0.08 | 0.09 | 0.136 | Urease inhibitor | 0.136 0.032 DBMET01778 | DBMET01778 | |
| 0.059 | 0.07 | 0.108 | Cathepsin G inhibitor | 0.108 0.03 DBMET01778 | DBMET01778 | |
| 0.023 | 0.036 | 0.066 | Plasma kallikrein inhibitor | 0.066 0.008 DBMET01778 | DBMET01778 | |
| 0.078 | 0.091 | 0.093 | Chemokine receptor antagonist | 0.093 0.071 DBMET01778 | DBMET01778 | |
| 0.074 | 0.088 | 0.1 | NADH dehydrogenase inhibitor | 0.1 0.044 DBMET00287 0.084 0.066 DBMET01778 | DBMET00287 | |
| 0.02 | 0.035 | 0.051 | Bradykinin B2 receptor agonist | 0.051 0.007 DBMET01778 | DBMET01778 | |
| 0.035 | 0.05 | 0.152 | GP IIb/IIIa receptor antagonist | 0.152 0.01 DBMET01778 | DBMET01778 | |
| 0.043 | 0.058 | 0.05 | Sodium/calcium exchanger inhibitor | 0.05 0.035 DBMET01778 | DBMET01778 | |
| 0.043 | 0.059 | 0.059 | Factor III inhibitor | 0.059 0.019 DBMET01778 | DBMET01778 | |
| 0.073 | 0.089 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.082 0.075 DBMET00287 0.173 0.018 DBMET01778 | DBMET01778 | |
| 0.045 | 0.062 | 0.082 | Glucagon-like peptide 1 agonist | 0.082 0.033 DBMET01778 | DBMET01778 | |
| 0.031 | 0.049 | 0.054 | Integrin alpha5beta1 antagonist | 0.054 0.015 DBMET01778 | DBMET01778 | |
| 0.119 | 0.138 | 0.153 | LIM domain kinase 1 inhibitor | 0.153 0.095 DBMET00287 0.143 0.105 DBMET01778 | DBMET00287 | |
| 0.011 | 0.032 | 0.106 | Melanocortin 3 antagonist | 0.106 0.011 DBMET01778 | DBMET01778 | |
| 0.028 | 0.051 | 0.04 | Oxytocin agonist | 0.04 0.032 DBMET01778 | DBMET01778 | |
| 0.004 | 0.029 | 0.011 | Protease activated receptor 1 agonist | 0.011 0.009 DBMET01778 | DBMET01778 | |
| 0.02 | 0.045 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.037 0.017 DBMET00287 0.032 0.021 DBMET01778 | DBMET00287 | |
| 0.019 | 0.045 | 0.046 | Arginase inhibitor | 0.046 0.018 DBMET01778 | DBMET01778 | |
| 0.007 | 0.033 | 0.017 | Protease activated receptor agonist | 0.017 0.013 DBMET01778 | DBMET01778 | |
| 0.008 | 0.035 | 0.06 | Melanocortin 1 agonist | 0.06 0.012 DBMET01778 | DBMET01778 | |
| 0.025 | 0.054 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.021 DBMET01778 | DBMET01778 | |
| 0.13 | 0.159 | 0.405 | Platelet aggregation inhibitor | 0.405 0.018 DBMET01778 | DBMET01778 | |
| 0.01 | 0.04 | 0.047 | Melanocortin agonist | 0.047 0.014 DBMET01778 | DBMET01778 | |
| 0.03 | 0.061 | 0.052 | Neurotensin receptor antagonist | 0.052 0.027 DBMET01778 | DBMET01778 | |
| 0.086 | 0.117 | 0.195 | Glutamate receptor antagonist | 0.195 0.027 DBMET01778 | DBMET01778 | |
| 0.041 | 0.073 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET01778 | DBMET01778 | |
| 0.01 | 0.043 | 0.032 | Melanocortin 4 agonist | 0.032 0.015 DBMET01778 | DBMET01778 | |
| 0.005 | 0.04 | 0.037 | Melanocortin 3 agonist | 0.037 0.014 DBMET01778 | DBMET01778 | |
| 0.037 | 0.073 | 0.086 | Factor IXa inhibitor | 0.086 0.014 DBMET01778 | DBMET01778 | |
| 0.004 | 0.042 | 0.024 | Melanocortin 5 agonist | 0.024 0.015 DBMET01778 | DBMET01778 | |
| 0.024 | 0.064 | 0.151 | Factor Xa inhibitor | 0.151 0.008 DBMET01778 | DBMET01778 | |
| 0.024 | 0.064 | 0.053 | Dihydropteroate synthase inhibitor | 0.053 0.015 DBMET01778 | DBMET01778 | |
| 0.019 | 0.061 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.022 DBMET01778 | DBMET01778 | |
| 0.027 | 0.07 | 0.061 | Acid-sensing ion channel blocker | 0.061 0.009 DBMET01778 | DBMET01778 | |
| 0.005 | 0.048 | 0.014 | Imidazoline I2 receptor antagonist | 0.014 0.005 DBMET01778 | DBMET01778 | |
| 0.044 | 0.088 | 0.063 | NMDA receptor agonist | 0.063 0.043 DBMET01778 | DBMET01778 | |
| 0.012 | 0.056 | 0.03 | Integrin alphaVbeta3 antagonist | 0.03 0.008 DBMET01778 | DBMET01778 | |
| 0.104 | 0.152 | 0.185 | Growth hormone agonist | 0.185 0.065 DBMET01778 | DBMET01778 | |
| 0.108 | 0.156 | 0.124 | Adenylate cyclase stimulant | 0.124 0.116 DBMET01778 | DBMET01778 | |
| 0.076 | 0.124 | 0.094 | Mucolytic | 0.094 0.086 DBMET01778 | DBMET01778 | |
| 0.034 | 0.083 | 0.047 | Histamine H4 receptor antagonist | 0.047 0.037 DBMET00287 | DBMET00287 | |
| 0.033 | 0.083 | 0.082 | H+/K+-transporting ATPase inhibitor | 0.082 0.012 DBMET01778 | DBMET01778 | |
| 0.025 | 0.081 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.009 DBMET00287 0.041 0.013 DBMET01778 | DBMET00287 | |
| 0.162 | 0.22 | 0.185 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.164 DBMET01778 | DBMET01778 | |
| 0.067 | 0.13 | 0.104 | Protein kinase C zeta inhibitor | 0.104 0.046 DBMET01778 | DBMET01778 | |
| 0.147 | 0.21 | 0.215 | DNA synthesis inhibitor | 0.215 0.102 DBMET00287 | DBMET00287 | |
| 0.035 | 0.105 | 0.055 | CD45 antagonist | 0.055 0.026 DBMET01778 | DBMET01778 | |
| 0.006 | 0.079 | 0.018 | Cyclin T1 inhibitor | 0.018 0.013 DBMET00287 | DBMET00287 | |
| 0.065 | 0.138 | 0.096 | Cystathionine beta-synthase inhibitor | 0.096 0.081 DBMET01778 | DBMET01778 | |
| 0.017 | 0.091 | 0.088 | Vascular adhesion protein 1 inhibitor | 0.088 0.005 DBMET01778 | DBMET01778 | |
| 0.118 | 0.197 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.098 DBMET00287 | DBMET00287 | |
| 0.126 | 0.205 | 0.611 | Streptokinase A inhibitor | 0.611 0.015 DBMET00287 0.18 0.146 DBMET01778 | DBMET00287 | |
| 0.149 | 0.241 | 0.337 | Angiogenesis inhibitor | 0.337 0.076 DBMET01778 | DBMET01778 | |
| 0.02 | 0.116 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET01778 | DBMET01778 | |
| 0.044 | 0.143 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 DBMET01778 | DBMET01778 | |
| 0.041 | 0.148 | 0.13 | Protein kinase B gamma inhibitor | 0.13 0.022 DBMET00287 0.071 0.056 DBMET01778 | DBMET00287 | |
| 0.134 | 0.243 | 0.223 | RNA-directed DNA polymerase inhibitor | 0.223 0.071 DBMET00287 | DBMET00287 | |
| 0.059 | 0.172 | 0.155 | Electrolyte absorption antagonist | 0.155 0.017 DBMET00287 0.086 0.083 DBMET01778 | DBMET00287 | |
| 0.051 | 0.167 | 0.1 | GABA B receptor agonist | 0.1 0.016 DBMET00287 0.08 0.043 DBMET01778 | DBMET00287 | |
| 0.098 | 0.214 | 0.126 | Death-associated protein kinase 1 inhibitor | 0.126 0.092 DBMET01778 | DBMET01778 | |
| 0.039 | 0.159 | 0.085 | Potassium channel (Ca-activated) activator | 0.085 0.07 DBMET01778 | DBMET01778 | |
| 0.03 | 0.153 | 0.042 | Heme oxygenase inhibitor | 0.042 0.034 DBMET01778 | DBMET01778 | |
| 0.009 | 0.136 | 0.028 | Complement C5a chemotactic receptor antagonist | 0.028 0.023 DBMET01778 | DBMET01778 | |
| 0.01 | 0.139 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.021 0.006 DBMET00287 0.016 0.015 DBMET01778 | DBMET00287 | |
| 0.085 | 0.229 | 0.133 | GABA C receptor rho-2 antagonist | 0.133 0.1 DBMET00287 | DBMET00287 | |
| 0.067 | 0.215 | 0.239 | Angiogenesis stimulant | 0.239 0.075 DBMET01778 | DBMET01778 | |
| 0.052 | 0.201 | 0.092 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.069 DBMET00287 | DBMET00287 | |
| 0.053 | 0.205 | 0.128 | Nav1.6 sodium channel blocker | 0.128 0.084 DBMET01778 | DBMET01778 | |
| 0.024 | 0.192 | 0.069 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 DBMET00287 | DBMET00287 | |
| 0.043 | 0.216 | 0.101 | GABA C receptor agonist | 0.101 0.066 DBMET01778 | DBMET01778 | |
| 0.028 | 0.236 | 0.094 | Check point kinase 2 inhibitor | 0.094 0.071 DBMET01778 | DBMET01778 | |
| 0.018 | 0.237 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.062 0.032 DBMET00287 | DBMET00287 | |
| 0.007 | 0.263 | 0.088 | Fructose-1,6-bisphosphatase inhibitor | 0.088 0.005 DBMET00287 | DBMET00287 | |
| 0.039 | 0.305 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.059 DBMET00287 | DBMET00287 | |
| 0.111 | 0.379 | 0.221 | Histamine release inhibitor | 0.221 0.18 DBMET00287 | DBMET00287 | |
| 0.072 | 0.349 | 0.153 | Neurotrophic factor enhancer | 0.153 0.134 DBMET00287 | DBMET00287 | |
| 0.05 | 0.328 | 0.109 | Interleukin 4 antagonist | 0.109 0.103 DBMET01778 | DBMET01778 | |
| 0.04 | 0.322 | 0.179 | Aryl hydrocarbon receptor agonist | 0.179 0.115 DBMET00287 | DBMET00287 | |
| 0.01 | 0.324 | 0.03 | Granulocyte colony stimulating factor receptor agonist | 0.03 0.003 DBMET00287 | DBMET00287 | |
| 0.015 | 0.349 | 0.091 | CDK2/cyclin E2 inhibitor | 0.091 0.031 DBMET00287 | DBMET00287 | |
| 0.035 | 0.373 | 0.082 | mTOR complex 2 inhibitor | 0.082 0.063 DBMET00287 | DBMET00287 | |
| 0.03 | 0.381 | 0.325 | Thioredoxin inhibitor | 0.325 0.003 DBMET00287 | DBMET00287 | |
| 0.01 | 0.413 | 0.075 | CDC7 inhibitor | 0.075 0.039 DBMET00287 | DBMET00287 | |
| 0.042 | 0.468 | 0.139 | Interleukin 6 antagonist | 0.139 0.108 DBMET01778 | DBMET01778 | |
| 0.011 | 0.454 | 0.105 | Purinergic P2X2 antagonist | 0.105 0.027 DBMET00287 | DBMET00287 | |
| 0.014 | 0.505 | 0.194 | Protein-tyrosine kinase Lyn inhibitor | 0.194 0.048 DBMET00287 | DBMET00287 | |
| 0.004 | 0.502 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.012 DBMET00287 | DBMET00287 | |
| 0.013 | 0.521 | 0.094 | 5 Hydroxytryptamine 2B antagonist | 0.094 0.09 DBMET00287 | DBMET00287 | |
| 0.015 | 0.545 | 0.175 | Protein kinase (CK1) gamma 1 inhibitor | 0.175 0.053 DBMET00287 | DBMET00287 | |
| 0.015 | 0.566 | 0.138 | Protein kinase (CK1) gamma 3 inhibitor | 0.138 0.104 DBMET00287 | DBMET00287 | |
| 0.009 | 0.617 | 0.097 | Protein kinase (CK1) gamma 2 inhibitor | 0.097 0.087 DBMET00287 | DBMET00287 | |
| 0.008 | 0.667 | 0.176 | Lck kinase inhibitor | 0.176 0.051 DBMET00287 | DBMET00287 | |
| 0.023 | 0.727 | 0.178 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.178 0.096 DBMET00287 | DBMET00287 | |
| 0.007 | 0.73 | 0.146 | Nicotinic acid receptor 1 agonist | 0.146 0.005 DBMET00287 | DBMET00287 | |
| 0.008 | 0.88 | 0.145 | Thioredoxin reductase inhibitor | 0.145 0.01 DBMET00287 | DBMET00287 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |